We are live on ! Find out more
AMED

Amedisys
AMED

Delisted

AMED was delisted on the 14th of August, 2025.

Back to rankings

285 hedge funds and large institutions have $3.51B invested in Amedisys in 2019 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 105 increasing their positions, 105 reducing their positions, and 75 closing their positions.

New
Increased
Maintained
Reduced
Closed

2.44% more ownership

Funds ownership: 88.11% → 90.56% (+2.4%)

1% more capital invested

Capital invested by funds: $3.47B → $3.51B (+$44.8M)

0% more repeat investments, than reductions

Existing positions increased: 105 | Existing positions reduced: 105

10% less funds holding

Funds holding: 317 → 285 (-32)

35% less first-time investments, than exits

New positions opened: 49 | Existing positions closed: 75

48% less call options, than puts

Call options by funds: $15.7M | Put options by funds: $30.5M

Holders
285
Holders Change
-32
Holders Change %
-10.09%
% of All Funds
6.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
49
Increased
105
Reduced
105
Closed
75
Calls
$15.7M
Puts
$30.5M
Net Calls
-$14.8M
Net Calls Change
+$1.33M

Top Buyers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$119M
2
William Blair Investment Management
William Blair Investment Management
Illinois
+$106M
3
RP
Riverbridge Partners
Minnesota
+$78.7M
4
EAM
Eagle Asset Management
Florida
+$34.6M
5
N
Nuveen
North Carolina
+$29.6M

Top Sellers

1
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$88.9M
2
Citadel Advisors
Citadel Advisors
Florida
-$33.3M
3
Millennium Management
Millennium Management
New York
-$26.7M
4
Ameriprise
Ameriprise
Minnesota
-$25.9M
5
JIM
Jupiter Investment Management
United Kingdom
-$23.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
SG Americas Securities
126
SG Americas Securities
New York
$1.78M +$1.32M +11,118 +310%
Stifel Financial
127
Stifel Financial
Missouri
$1.71M +$1.65M +13,932 New
KBC Group
128
KBC Group
Belgium
$1.62M -$117K -983 -7%
SCM
129
Sterling Capital Management
North Carolina
$1.57M – – –
FP
130
Foundry Partners
Minnesota
$1.56M -$1.56M -13,127 -51%
SO
131
STRS Ohio
Ohio
$1.54M +$119K +1,000 +9%
SRAM
132
Stone Ridge Asset Management
New York
$1.49M -$71.2K -600 -5%
SBH
133
Segall Bryant & Hamill
Illinois
$1.47M +$6.05K +51 +0.4%
GCP
134
GSA Capital Partners
United Kingdom
$1.45M -$147K -1,240 -9%
ACM
135
Argent Capital Management
Missouri
$1.45M +$4.15K +35 +0.3%
BPM
136
Bowling Portfolio Management
Ohio
$1.44M -$225K -1,900 -14%
Pacer Advisors
137
Pacer Advisors
Pennsylvania
$1.42M +$1.39M +11,712 New
CSS
138
Cubist Systematic Strategies
Connecticut
$1.42M +$1.17M +9,886 +546%
Millennium Management
139
Millennium Management
New York
$1.41M -$26.7M -225,180 -95%
Morgan Stanley
140
Morgan Stanley
New York
$1.39M -$5.79M -48,815 -81%
VRS
141
Virginia Retirement Systems
Virginia
$1.26M -$59.3K -500 -5%
MSL
142
Mackay Shields LLC
New York
$1.25M -$795K -6,700 -39%
Tudor Investment Corp
143
Tudor Investment Corp
Connecticut
$1.24M -$3.91M -32,911 -76%
EF
144
Empowered Funds
Pennsylvania
$1.23M -$176K -1,487 -13%
SFM
145
Systematic Financial Management
New Jersey
$1.16M -$698K -5,880 -38%
Jennison Associates
146
Jennison Associates
New York
$1.13M +$79.9K +673 +8%
CIC
147
Cornercap Investment Counsel
Georgia
$1.12M -$11.9K -100 -1%
FDCDDQ
148
Federation des caisses Desjardins du Quebec
Quebec, Canada
$1.12M +$42.7K +360 +4%
ERSOT
149
Employees Retirement System of Texas
Texas
$1.09M -$119K -1,000 -10%
OSAM
150
O'Shaughnessy Asset Management
Connecticut
$1.09M -$120K -1,012 -10%
4 5
6
7 8

AMED Hedge Fund Activity: Q2 2019 in Review

285 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q2 2019, worth a combined $3.51B — up 1.3% from $3.47B a quarter earlier.

Sellers outnumbered buyers: 75 funds closed out of AMED and 49 opened new positions — a net loss of 26 holders — while 105 trimmed existing stakes and 105 added.

The largest buyer was T. Rowe Price Associates, adding an estimated $119M. The largest seller was Acadian Asset Management, exiting entirely with an estimated $88.9M sold.

  • 285 institutional investors held Amedisys (AMED) as of Q2 2019, down from 317 in Q1 2019.
  • Funds reported $3.51B of Amedisys stock for Q2 2019, up 1.3% quarter-over-quarter.
  • 49 funds opened new Amedisys positions in Q2 2019 and 75 closed out, a net change of -26 holders.
  • The largest Amedisys buyer in Q2 2019 was T. Rowe Price Associates, an estimated $119M added.
  • The largest Amedisys seller in Q2 2019 was Acadian Asset Management, an estimated $88.9M sold.

Based on aggregated 13F filings for Q2 2019.